Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,591 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immunogenicity and Safety of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Vaccine Given 1 Year After Primary Immunization in Healthy Children in the Republic of Korea.
Kim DS, Jang GC, Cha SH, Choi SH, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Bang J, Naimi Z, Bouckenooghe A, Bosch-Castells V, Houillon G. Kim DS, et al. Among authors: bang j. Pediatr Infect Dis J. 2016 Feb;35(2):e60-4. doi: 10.1097/INF.0000000000000967. Pediatr Infect Dis J. 2016. PMID: 26535878 Clinical Trial.
A randomized study of the immunogenicity and safety of Japanese encephalitis chimeric virus vaccine (JE-CV) in comparison with SA14-14-2 vaccine in children in the Republic of Korea.
Kim DS, Houillon G, Jang GC, Cha SH, Choi SH, Lee J, Kim HM, Kim JH, Kang JH, Kim JH, Kim KH, Kim HS, Bang J, Naimi Z, Bosch-Castells V, Boaz M, Bouckenooghe A. Kim DS, et al. Among authors: bang j. Hum Vaccin Immunother. 2014;10(9):2656-63. doi: 10.4161/hv.29743. Epub 2014 Nov 6. Hum Vaccin Immunother. 2014. PMID: 25483480 Free PMC article. Clinical Trial.
Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.
Kim DS, Kim MJ, Cha SH, Kim HM, Kim JH, Kim KN, Lee JS, Choi JY, Castells VB, Kim HS, Bang J, Oster P. Kim DS, et al. Among authors: bang j. Int J Infect Dis. 2016 Apr;45:59-64. doi: 10.1016/j.ijid.2016.02.010. Epub 2016 Feb 24. Int J Infect Dis. 2016. PMID: 26921548 Free article. Clinical Trial.
Immunogenicity and safety of a fully liquid DTaP-IPV-HB-PRP∼T hexavalent vaccine compared with the standard of care in infants in the Republic of Korea.
Kim YK, Vidor E, Kim HM, Shin SM, Lee KY, Cha SH, Ma SH, Kim DH, Lee J, Park SE, Lee H, Kim JD, Kim KH, Kim KH, Kim JH; A3L31 Study Group. Kim YK, et al. Vaccine. 2017 Jul 13;35(32):4022-4028. doi: 10.1016/j.vaccine.2017.05.062. Epub 2017 Jun 16. Vaccine. 2017. PMID: 28629923 Clinical Trial. No abstract available.
An 8-Year Prospective, Observational, Multi-centre Post-Marketing Safety Surveillance Study Conducted in South Korea (2014-2022) Following the Introduction of GSK's Inactivated Quadrivalent Seasonal Influenza Vaccine (Fluarix Tetra) for Subjects Aged 6 Months and Older.
Dos Santos G, Devadiga R, Kim CS, Bang J. Dos Santos G, et al. Among authors: bang j. Drug Saf. 2024 Apr;47(4):365-375. doi: 10.1007/s40264-024-01395-8. Epub 2024 Mar 14. Drug Saf. 2024. PMID: 38483767 Free PMC article.
1,591 results